Trident Lifeline Ltd

BSE: 543616 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹395.95
Market cap: ₹467.1 Cr
Revenue (annual): ₹129.0 Cr
Net profit (annual): ₹19.04 Cr
P/E (TTM): 24.5×Sector 47.4×
Promoter holding: 62.46%-0.39% QoQ
FII holding: 4.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Business Update 3 Annual General Meeting 3 Capital Structure Change 2 SME to Main Board Migration 1 Price Movement Clarification 1 Other Announcement 1 Financial Results 1 Earnings Call 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

8 Sep 2026 19:02 IST BSE

Business Update

Trident Lifeline Business Update

Trident Lifeline Limited received an award from PHARMEXCIL for its contribution to India's pharmaceutical exports. This recognition highlights the company's growth in global markets.

Read the filing ↗

31 Aug 2026 13:53 IST BSE

Business Update

Trident Lifeline Business Update

Trident Lifeline Ltd has been selected for the 'Outstanding Contribution to India's Pharmaceutical Exports' award by PHARMEXCIL. The award ceremony is scheduled for September 7, 2026.

Read the filing ↗

17 Aug 2026 15:15 IST BSE

Business Update

Trident Lifeline Business Update

Trident Lifeline Limited has been selected for the 'Fastest Growing SMEs' award by India SME Forum and Axis Bank in the Top 50 SME Awards - Gujarat.

Read the filing ↗